SelectQuote, Inc. Announces 1-for-20 Reverse Stock Split
Key Highlights
- ➤1-for-20 reverse split targets NYSE minimum stock-price compliance
- ➤Split effective November 16; split-adjusted trading begins November 17
- ➤Outstanding shares cut from 180,185,985 to approximately 9,009,299
- ➤Authorized shares reduced from 700,000,000 to 35,000,000
- ➤SelectQuote expects more than $60 million operating cash flow this year
Expert Statements
Tim Danker, CEO of SelectQuote
“This is an important step that aligns with our commitment to remain listed on the NYSE. While we do not believe our current equity valuation reflects the strength of our business, SelectQuote remains an industry leader with a compelling opportunity ahead. Our differentiated insurance distribution and healthcare services businesses, improving cash flow profile, and strong balance sheet provide a solid foundation for continued growth. We expect to generate more than $60 million in operating cash flow this year and have a commissions receivable balance in excess of $1 billion. Together, these strengths position SelectQuote to continue innovating, leading our markets, and delivering world-class service to the millions of customers we serve.”
SelectQuote, Inc. (NYSE: SLQT) (“SelectQuote” or the “Company”) today announced that its board of directors (the “Board”) has approved a 1-for-20 reverse stock split of the Company’s common stock and a proportionate reduction in the number of authorized shares of common stock. At the Company’s Annual Meeting of Stockholders (the “Annual Meeting”) on November 10, 2026, the Company’s stockholders approved an amendment to the Company’s Sixth Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-10 and 1-for-20, with the exact ratio to be determined by the Board.
The reverse stock split is intended to help the Company regain compliance with the minimum stock price requirement for continued listing on the New York Stock Exchange.
Get started
Create a free account to read the full story.